3-Piperidinol, 2-[(3b,5a,16a,20S)-3-amino-16-hydroxypregnan-20-yl]-5-methyl-, (2R,3S,5R)- (9CI) (63785-22-8)

Identification
Name:	3-Piperidinol, 2-[(3b,5a,16a,20S)-3-amino-16-hydroxypregnan-20-yl]-5-methyl-, (2R,3S,5R)- (9CI)
Synonyms:	16,28-Secosolanidane-16,23-diol,3-amino-, (3b,5a,16a,22a,23b,25b)-; Solacapine
CAS:	63785-22-8
Molecular Formula:	C27H48 N2 O2
Molecular Weight:	0
InChI:	InChI=1/C27H48N2O2/c1-15-11-23(31)25(29-14-15)16(2)24-22(30)13-21-19-6-5-17-12-18(28)7-9-26(17,3)20(19)8-10-27(21,24)4/h15-25,29-31H,5-14,28H2,1-4H3/t15-,16+,17+,18+,19-,20+,21+,22-,23+,24+,25-,26+,27+/m1/s1
Molecular Structure:
Properties
Flash Point:	293.3°C
Boiling Point:	561.4°C at 760 mmHg
Density:	1.064g/cm³
Refractive index:	1.536
Flash Point:	293.3°C
Safety Data

Other Product

3-Piperidinol,2-[(3â,5R,16R,20S)-3-amino- 16-hydroxypregnan-20-yl]-5-methyl-,(2R,- 3R,5R)-
Pregnan-4-one,16-(acetyloxy)-3-hydroxy-20-[(2R,3S,5R)-3-hydroxy-5-methyl-2-piperidinyl]-, (3b,5a,16a,20S)-
Benzamide, N-[(3b,4b,5a,16b,20S)-4-(acetyloxy)-20-(dimethylamino)-16-hydroxypregnan-3-yl]-N-methyl-(9CI)
Benzamide, N-[(2b,3b,4b,5a,20S)-4-(acetyloxy)-20-(dimethylamino)-2-hydroxypregnan-3-yl]-(9CI)
2-Butenamide, N-[(2b,3b,4b,5a,20S)-4-(acetyloxy)-20-(dimethylamino)-2-hydroxypregnan-3-yl]-2-methyl-,(2E)- (9CI)
9,19-Cyclopregnan-16-ol,3-amino-20-(dimethylamino)-4,4,14-trimethyl-, (3b,5a,16a,20S)- (9CI)
Benzamide, N-[(3b,4b,5a,20S)-20-(dimethylamino)-4-hydroxypregnan-3-yl]- (9CI)
Acetamide,N-[(3b,5a,20S)-20-(dimethylamino)-18-hydroxypregnan-3-yl]- (9CI)
Benzamide, N-[(3b,4b,5a,12b,20S)-4-(acetyloxy)-20-(dimethylamino)-12-hydroxypregnan-3-yl]-N-methyl-(9CI)
b-D-Galactopyranoside, (3b,16a,20S)-16-hydroxy-20-[(5S)-5-methyl-2-piperidinyl]pregn-5-en-3-yl(9CI)
Pregnane-3,16-diol,20-[(5R)-3,4,5,6-tetrahydro-5-methyl-2-pyridinyl]-, (3b,5a,16a,20S)- (9CI)
Pregnan-4-one,3,16-dihydroxy-20-[(2R,3S,5R)-3-hydroxy-5-methyl-2-piperidinyl]-, (3b,5a,16a,20R)-
Pregn-5-ene-3,16-diol,20-[(2R,5R)-5-methyl-2-piperidinyl]-, (3b,16a,20S)- (9CI)
9,19-Cyclopregnan-16-ol,3-(dimethylamino)-14-methyl-20-(methylamino)-4-methylene-, (3b,5a,16a,20S)- (9CI)
Benzamide, N-[(3a,4b,5a,16b,20S)-4-(acetyloxy)-20-(dimethylamino)-16-hydroxypregnan-3-yl]-N-methyl-
Pregn-5-ene-3,15,16-triol,20-[(5R)-3,4,5,6-tetrahydro-5-methyl-2-pyridinyl]-, 16-acetate, (3b,15b,16a,20S)- (9CI)
Benzamide, N-[(3b,4a,5a,16a,20S)-20-(dimethylamino)-16-hydroxy-4-(hydroxymethyl)-4,14-dimethyl-9,19-cyclopregn-6-en-3-yl]-N-methyl-(9CI)
9,19-Cyclopregn-6-en-16-ol,3-(dimethylamino)-4,4,14-trimethyl-20-(methylamino)-, (2E)-2-methyl-2-butenoate(ester), (3b,5a,16a,20S)- (9CI)
b-D-Glucopyranoside, (3b,16a,20S)-16-hydroxy-20-[(2S,5S)-5-methyl-2-piperidinyl]pregn-5-en-3-yl(9CI)
b-D-Glucopyranoside, (3b,16a,20S)-16-(acetyloxy)-20-[(5S)-3,4,5,6-tetrahydro-5-methyl-2-pyridinyl]pregn-5-en-3-yl(9CI)